{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:19:40Z","timestamp":1697451580707},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,5,28]],"date-time":"2003-05-28T00:00:00Z","timestamp":1054080000000},"content-version":"vor","delay-in-days":88,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Therapeutics"],"published-print":{"date-parts":[[2003,3]]},"abstract":"<jats:p>Cysteine cathepsin B and its endogenous inhibitor play an important role in tumor progression. Increase in cathepsin B expression and reduced levels of its inhibitors were associated with tumor malignancy in breast cancer. The objective of this study was to investigate the effects of a new therapy combining vitamin E and placental inhibitor on the level of endogenous protease inhibitor in sera and tumor tissues with mammary cancer. The inhibitor was used in doses of 100 and 200\u2003\u03bcg per animal for 8 days. Vitamin E was added after the last treatment with inhibitor and was injected daily in doses of 10 and 20\u2003mg per animal for one mouth. The size and survival time of treated animals as well as cathepsin B and the inhibitor activity in tumor and sera before and after treatment in comparison with the control groups were determined. The activity of cathepsin B significantly decreased both in tumor tissues and in sera (<jats:italic>P<\/jats:italic>\u2003\u2264\u20030.0001). Cathepsin B activity in tumor tissue homogenates and in sera decreased two\u2010fold and three\u2010fold, respectively, after the animals were treated with vitamin E at a dose of 20\u2003mg, and decreased five\u2010fold and 15\u2010fold, respectively, when treated with vitamin E plus inhibitor in comparison with untreated animals. Endogenous inhibitor activity increased six\u2010fold and 12\u2010fold in the sera and tissue homogenates, respectively, after the animals were treated with 200\u2003\u03bcg of cysteine protease inhibitor plus 20\u2003mg of vitamin E, in comparison with untreated animals. The total cure responses were higher in eight of 10 rats, as compared with untreated animals. The combination of placental inhibitor and vitamin E resulted in a significant reduction in breast metastasis and might provide a therapeutic basis for anti\u2010metastasis therapy.<\/jats:p>","DOI":"10.1046\/j.1359-4117.2003.01077.x","type":"journal-article","created":{"date-parts":[[2003,5,28]],"date-time":"2003-05-28T14:18:05Z","timestamp":1054131485000},"page":"95-102","source":"Crossref","is-referenced-by-count":2,"title":["Effects of combined in vivo treatment of transplantable solid mammary carcinoma in Wistar rats using vitamin E and cysteine peptidase inhibitors from human placenta"],"prefix":"10.1111","volume":"3","author":[{"given":"Yousif","family":"Saleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Siewi\u00f1ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadeusz","family":"Sebzda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Grybos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Pawelec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Janocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,5,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2510-3_13"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2000.5948"},{"issue":"5","key":"e_1_2_5_4_2","first-page":"549","article-title":"Vitamin E and benign breast disease","volume":"107","author":"Meyer EC","year":"1990","journal-title":"Surgery"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00132746"},{"key":"e_1_2_5_6_2","first-page":"904","article-title":"Control of breast tumor cell growth using a targeted cysteine protease inhibitor","volume":"58","author":"Xing R","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642463"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.476"},{"key":"e_1_2_5_9_2","unstructured":"SalehY Zi\u00f3lkowskiP Siewi\u00f1skiM MilachJ MarszalikP RybkaJ.The combined treatment of transplantable solid mammary carcinoma in Wistar rats by use of photodynamic therapy and cysteine proteinase inhibitor.In Vivo15:351\u2013358 2001."},{"key":"e_1_2_5_10_2","first-page":"33","article-title":"Method of purification of thiol proteinase inhibitors from human urine","volume":"12","author":"Siewi\u00f1ski M.","year":"1991","journal-title":"Cancer Biochem Biophys"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(88)90546-3"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.1996.tb00052.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018494020001"},{"key":"e_1_2_5_15_2","first-page":"47","article-title":"Methods of blood collection in the mouse","volume":"29","author":"Hoff J","year":"2000","journal-title":"Lab Anim Tech"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(81)80043-2"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj1870909"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2510-3_13"},{"key":"e_1_2_5_19_2","first-page":"407","volume-title":"Cancer Causes Control","author":"Ambrosone CB","year":"1995"},{"key":"e_1_2_5_20_2","first-page":"125","article-title":"Cysteine proteinases in cancer progression and their clinical relevance for prognosis","volume":"379","author":"Lah TT","year":"1998","journal-title":"Biol Chem"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0098-2997(94)90033-7"},{"key":"e_1_2_5_22_2","first-page":"131","article-title":"In vivo effect of vitamin E on peritoneal macrophages and T\u2010kininogen level rats","volume":"59","author":"Sakamoto W","year":"1989","journal-title":"Int J Vitam Nutr Res"},{"key":"e_1_2_5_23_2","first-page":"59","article-title":"Influence of vitamin E on preventive or therapeutic effect of MFA and DTPA in cadmium toxicity","volume":"8","author":"Tandon SK","year":"1995","journal-title":"Biomed Environ Sci"},{"key":"e_1_2_5_24_2","first-page":"69","article-title":"Cathepsins B, H, and L in human breast carcinoma","volume":"30","author":"Gabrijelcic D","year":"1992","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940701)74:1<46::AID-CNCR2820740109>3.0.CO;2-G"},{"key":"e_1_2_5_26_2","first-page":"895","article-title":"Prognostic value of increased lung tumor tissue cathepsin B","volume":"14","author":"Ebert W","year":"1994","journal-title":"Anticancer Res"},{"key":"e_1_2_5_27_2","first-page":"1137","article-title":"Stage specific increases in cathepsin B messenger RNA content inhuman colorectal carcinoma","volume":"51","author":"Murnane MJ","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_5_28_2","first-page":"741","article-title":"Prognostic values of the cysteine protease cathepsin B and L in human breast cancer","volume":"1","author":"Thomssen C","year":"1995","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Experimental Therapeutics and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1359-4117.2003.01077.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1359-4117.2003.01077.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1359-4117.2003.01077.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:41:38Z","timestamp":1697348498000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1359-4117.2003.01077.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["10.1046\/j.1359-4117.2003.01077.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1359-4117.2003.01077.x","archive":["Portico"],"relation":{},"ISSN":["1359-4117","1533-869X"],"issn-type":[{"value":"1359-4117","type":"print"},{"value":"1533-869X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}